Background Lymphedema is a chronic condition characterized by progressive edema with complicated treatment. Recently, new treatment strategies inducing lymphangiogenesis were proposed. The aim of our study was to examine the effect of vascular endothelial growth factor C (VEGF-C) and adipose-derived stem cells (ADSCs) on lymphatic regeneration and drainage re-establishment in vascularized lymph node transfer (VLNT) model using a pedicled vascularized lymph node (VLN) groin flap.
Methods Female Lewis rats with groin VLN flaps were utilized as a lymphedema model. Group A served as the control. Group B received VEGF-C. Group C received both VEGF-C and ADSCs. Group D received ADSCs only. Lymphatic drainage re-establishment was evaluated by ultrasound–photoacoustic imaging (US-PAI) after indocyanine green (ICG) injection.
Results The fastest regeneration of elevated flaps was observed in Groups B and C in all monitored periods. After the first month, ICG positivity was detected in 14.3% of animals in Group A, 71.43% of animals in Group B (odds ratio [OR] = 15; p = 0.048), and 83.33% in Group C (OR = 30; p = 0.027). On the contrary, the difference between control group and Group D (16.67%; p = 0.905) was statistically insignificant. Administration of VEGF-C, ADSC + VEGF-C, and ADSC led to full flap regeneration after 6 months. The control group had the lowest percentage of ICG positivity at all monitored time points.
Conclusion We found that the fastest regeneration occurred with the combination of the VLN flap and VEGF-C. The addition of ADSC had an insignificant effect in our study. Furthermore, we proved the feasibility of PAI as an assessment tool of the lymphatic drainage recovery in a VLNT model.
Keywords VEGF - ADSC - vascularized lymph node transfer - VLNT - lymphatic regeneration Ethics Approval and Consent to ParticipateThis study was performed in strict accordance with the Institutional Animal Care and Use Committee (MSMT-9993/2017-4). All surgeries were performed under anesthesia, and all efforts were made to minimize suffering.
Not applicable.
All data generated or analyzed during this study are included in this published article.
F.J. contributed to conception design of the work; animal experiments, acquisition, analysis, interpretation of data; and drafted the work. P.K., P.P., and J.P. helped in acquisition, analysis, and interpretation of imaging data. M.H.K. helped in acquisition, analysis, and interpretation of data in stem cells experiments and drafted the work or substantively revised it. J.M. performed animal experiments. A.S. and M.M. contributed to conception design of the work. K.S. drafted the work. L.S. contributed to conception design of the work and revision. O.M. contributed to conception design of the work; helped in analysis and interpretation of data; and drafted the work and substantively revised it. All authors read and approved the final manuscript.
Publication HistoryReceived: 01 February 2022
Accepted: 29 June 2022
Accepted Manuscript online:
11 July 2022
Article published online:
22 November 2022
© 2022. Thieme. All rights reserved.
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
留言 (0)